News

IRICoR to attend BIO-EUROPE Spring 2017

The Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR) of Université de Montréal will attend the 11th Annual International Partnering Conference BIO-EUROPE Spring. This conference is being held from March 20 to March 22, 2017 at the CCIB Convention Center in Barcelona, Spain.
For more information about BIO-EUROPE Spring 2017 click here : BIO-EUROPE Spring 2017
For a meeting […]

New antithrombotic drug developed through a research partnership between IRIC and Bristol-Myers Squibb

An article describing the identification and development of a new molecule to treat thrombotic diseases via a partnership with Bristol-Myers Squibb (BMS) was published in the January 4 edition of the prestigious scientific journal Science Translational Medicine.
This molecule, BMS-986120, acts on cellular receptor PAR4 involved in the activation of blood platelets in clot formation. Thus, it reduces considerably […]

ONCOPOLE: A research, development, and investment hub to accelerate the fight against cancer

A $15 million investment from Merck
Merck & Co., Inc., and the Fonds de recherche du Québec – Santé (FRQS) are proud to announce the creation of Oncopole: a research, development, and investment hub to accelerate the fight against cancer. The Oncopole is starting with a solid foundation with a $15-million financial commitment over three years from Merck. The funds will […]

WORLD CANCER DAY

Thank you for helping us fight cancer

PLEASE GIVE GENEROUSLY: all donations will go directly to cancer research.
 
INVITATION: Breakfast conference
Immunotherapy: When cancer cells meet serial killers (lecture given in French)
Conference summary
February 3, 2017, 7-8:30 am
Morris-and-Rosalind-Goodman Agora, at the Institute for Research in Immunology and Cancer
How to get to IRIC
Registration is free. Places […]

IRICoR congratulates Dr. Michel Bouvier for his Julius Axelrod Award

Michel Bouvier receives the Julius Axelrod Award for his contributions as a scientist and mentor
Professor Michel Bouvier, Chief Executive Officer of the Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal (UdeM) and professor in the Department of Biochemistry and Molecular Medicine of the Faculty of Medicine, was named recipient of the Julius Axelrod Award […]

Launch of phase II clinical trials for a molecule jointly identified by IRIC and Bristol-Myers Squibb

IRIC expands its medicinal chemistry core facility and announces the launch of phase II clinical trials for a molecule jointly identified by IRIC and Bristol-Myers Squibb
 
 
Representatives from provincial and federal governments, IRIC, IRICoR, Bristol-Myers Squibb (BMS), and life sciences sector.
Montreal, December 15, 2016 — On Wednesday, December 14, new laboratories for the medicinal core facility at the Institute for Research in […]

IRICoR is pleased to share news from our partner, Domain Therapeutics.

Domain Therapeutics grants Alkermes a non-exclusive license for its G Protein-Coupled Receptor BioSens-All™ technology
Technology provides access to a new set of sensitive biosensors that will facilitate drug discovery
Strasbourg, France, December 14, 2016 – Domain Therapeutics, a France- and Quebec-based biopharmaceutical company that specializes in the research and development of new drug candidates that target G protein-coupled receptors (GPCRs), announces […]

Integrate innovation into the health system – Interview IRICoR

At the Strategic Life Sciences Forum, hosted by The Chamber of Commerce of Metropolitan Montreal on November 7, 2016, Nadine Beauger, Chief Executive Officer of IRICoR (Institute for Research in Immunology and Cancer – Commercialization of Research), gave an interview to answer the question “How to integrate innovation into the health system?”. To view the interview click here (only […]

FORUM STRATÉGIQUE SUR LES SCIENCES DE LA VIE – The Importance of the Sector for Quebec

Montreal, November 14, 2016 – On November 7, The Chamber of Commerce of Metropolitan Montreal held the Forum Stratégique sur les Sciences de la vie attended by more than 400 participants from the industry, and from the research, innovation and health sectors. The Forum particularly aimed to highlight the economic importance of Life sciences in Quebec. Nadine Beauger, Chief Executive […]

IRICoR – Finalist for ADRIQ’s Prix Innovation | Sciences de la vie 2016

From left to right : Mrs. Anne Marinier, Principal Investigator and Director of the Medicinal Chemistry Core Facility at IRIC of the Université de Montréal, Mr. Pascal Monette, President and CEO of the ADRIQ and Mrs. Nadine Beauger, CEO of IRICoR
 
Université de Montréal’s Institute for Research in Immunology and Cancer (IRIC) – Commercialization of Research (IRICoR) based at IRIC has […]

Next Page »